Mária Mareková

Prof. Dr. Mária Mareková

Department of Medical and Clinical Biochemistry, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Tr. SNP 1, 040 11 Košice, Slovakia
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1993 in Letters in Applied Microbiology
Verified
Journal Article
Open access
PDF file
ALA. Lauková
A. Lauková
MMMária Mareková
Mária Mareková
PJP. Javorský
P. Javorský
Enterococcus faecium CCM4231, isolated from the rumen content of a calf, produced an antimicrobial agent active against Gram-positive and Gram-negative indicator organisms. After 100-fold concentration by ultrafiltration, the diameters of zones of inhibition ranged from 2 to 10 mm. The agent was sensitive to pronase and trypsin and resistant to heating at 60°C for 30 min.

6 June 2007 in Journal of Industrial Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
MMMária Mareková
Mária Mareková
ALAndrea Lauková
Andrea Lauková
MSMorten Skaugen
Morten Skaugen
INIngolf Nes
Ingolf Nes
The new bacteriocin, termed enterocin M, produced by Enterococcus faecium AL 41 showed a wide spectrum of inhibitory activity against the indicator organisms from different sources. It was purified by (NH4)2SO4 precipitation, cation-exchange chromatography and reverse phase chromatography (FPLC). The purified peptide was sequenced by N-terminal amino acid Edman degradation and a mass spectrometry analysis was performed. By combining the data obtained from amino acid sequence (39 N-terminal amino acid residues was determined) and the molecular weight (determined to be 4 628 Da) it was concluded that the purified enterocin M is a new bacteriocin, which is very similar to enterocin P. However, its molecular weight is different from enterocin P (4 701.25). Of the first 39 N-terminal residues of enterocin M, valine was found in position 20 and a lysine in position 35, while enterocin P has tryptophane residues in these positions.

1 March 2003 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
MMMária Mareková
Mária Mareková
ALA. Laukova
A. Laukova
LVLuc De Vuyst
Luc De Vuyst
MSM. Skaugen
M. Skaugen
INI.F. Nes
I.F. Nes
Aims: The partial characterization of bacteriocins produced by an environmental strain Enterococcus faecium EK13, isolated from cattle dung water. Methods and Results: A bacteriocin was partially pur...

24 June 2021 in Molecules
Verified
Journal Article
Open access
PDF file
DVDominika Veselinyová
Dominika Veselinyová
JMJana Maslankova
Jana Maslankova
KKKatarina Kalinová
Katarina Kalinová
HMHelena Mičková
Helena Mičková
MMMária Mareková
Mária Mareková
MRMiroslava Rabajdova
Miroslava Rabajdova
We are experiencing rapid progress in all types of imaging techniques used in the detection of various numbers and types of mutation. In situ hybridization (ISH) is the primary technique for the discovery of mutation agents, which are presented in a variety of cells. The ability of DNA to complementary bind is one of the main principles in every method used in ISH. From the first use of in situ techniques, scientists paid attention to the improvement of the probe design and detection, to enhance the fluorescent signal intensity and inhibition of cross-hybrid presence. This article discusses the individual types and modifications, and is focused on explaining the principles and limitations of ISH division on different types of probes. The article describes a design of probes for individual types of in situ hybridization (ISH), as well as the gradual combination of several laboratory procedures to achieve the highest possible sensitivity and to prevent undesirable events accompanying hybridization. The article also informs about applications of the methodology, in practice and in research, to detect cell to cell communication and principles of gene silencing, process of oncogenesis, and many other unknown processes taking place in organisms at the DNA/RNA level.

1 March 2014 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
Peter JarcuskaPeter Jarcuska
Peter Jarcuska
MJMartin Janicko
Martin Janicko
Peter KruzliakPeter Kruzliak
Peter Kruzliak
MNMiroslav Novák
Miroslav Novák
EVEduard Veseliny
Eduard Veseliny
EKEva Kolesárová
Eva Kolesárová

1 December 2013 in Central European Journal of Public Health
Verified
Journal Article
Open access
PDF file
MRMiroslava Rabajdova
Miroslava Rabajdova
ABAnna Birková
Anna Birková
PUPeter Urban
Peter Urban
KGKristína Gregová
Kristína Gregová
EĎEva Ďurovcová
Eva Ďurovcová
MMMária Mareková
Mária Mareková
Cancer chemoprevention is defined as the use of natural, synthetic or biological chemical agents to reverse, suppress or prevent carcinogenic progression of invasive cancer. Carcinogenesis is a complex multi-step process; therefore, it is nece...